Cancer-associated fibrosis promotes therapeutic resistance and immune evasion in pancreatic cancer [43,44,51,52] and recent evidence implicates GH as a covert driver of multi-tissue fibrosis [8]. The gene discussed is GH1; the disease is cancer.